THE US Food and Drug Authority
has approved the first generic version
of Effexor XR extended release
capsules (venlafaxine hydrochloride)
for the treatment of depression.
Approved in 37.5mg, 75mg and
150mg doses, the generic
venlafaxine hydrochloride capsules
are now set to be manufactured by
TEVA Pharmaceuticals.
The FDA has however warned
that the generic’s prescribing
informationwill differ from Effexor
XR, because some of the drug’s
uses and label components are still
protected by patents.
For more info see www.fda.gov.The above article was sent to subscribers in Pharmacy Daily's issue from 30 Jun 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 Jun 10
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.